Clinical course of patients with non-small cell lung cancer and epidermal growth factor receptor exon 19 and exon 21 mutations treated with gefitinib or erlotinib (Q46934958)
scientific article published in February 2006
Language:
Current Data About Clinical course of patients with non-small cell lung cancer and epidermal growth factor receptor exon 19 and exon 21 mutations treated with gefitinib or erlotinib
(P31) (Q13442814)
(P248)
(P698) 16467097
(P813) Tuesday, December 26, 2017
(P854) http://europepmc.org/abstract/MED/16467097

(P50) (Q37621431)
(P1545) 8
(P248)
(P698) 16467097
(P813) Tuesday, December 26, 2017
(P854) http://europepmc.org/abstract/MED/16467097

(Q28025149)
(P1545) 2
(P1932) William Pao
(P248)
(P698) 16467097
(P813) Tuesday, December 26, 2017

(Q28468944)
(P1545) 9
(P1932) Marc Ladanyi
(P248)
(P698) 16467097
(P813) Tuesday, December 26, 2017

(Q96189970)
(P1545) 1
(P1932) Gregory J Riely
(P248)
(P698) 16467097
(P813) Tuesday, December 26, 2017
(P854) http://europepmc.org/abstract/MED/16467097

(Q114291510)
(P1545) 7
(P1932) Maureen F Zakowski
(P248)
(P698) 16467097
(P813) Tuesday, December 26, 2017
(P854) http://europepmc.org/abstract/MED/16467097

(Q96231524)
(P1545) 5
(P1932) Naiyer Rizvi
(P248)
(P698) 16467097
(P813) Tuesday, December 26, 2017
(P854) http://europepmc.org/abstract/MED/16467097

(P304) 839-844
(P248)
(P698) 16467097
(P813) Tuesday, December 26, 2017
(P854) http://europepmc.org/abstract/MED/16467097

(P407) (Q1860)

(P433) 3 Pt 1
(P248)
(P698) 16467097
(P813) Tuesday, December 26, 2017
(P854) http://europepmc.org/abstract/MED/16467097

(P478) 12
(P248)
(P698) 16467097
(P813) Tuesday, December 26, 2017
(P854) http://europepmc.org/abstract/MED/16467097

(P577) Wednesday, February 1, 2006
(P248)
(P698) 16467097
(P813) Tuesday, December 26, 2017
(P854) http://europepmc.org/abstract/MED/16467097

(P921) (Q181600)

(Q3658562)
(P887)

(Q418369)
(P887)

(P1433) (Q332253)
(P248)
(P698) 16467097
(P813) Tuesday, December 26, 2017
(P854) http://europepmc.org/abstract/MED/16467097

(P1476) "Clinical course of patients with non-small cell lung cancer and epidermal growth factor receptor exon 19 and exon 21 mutations treated with gefitinib or erlotinib" (language: en)
(P248)
(P698) 16467097
(P813) Tuesday, December 26, 2017
(P854) http://europepmc.org/abstract/MED/16467097

(P2093) Duykhanh Pham
(P1545) 3
(P248)
(P698) 16467097
(P813) Tuesday, December 26, 2017
(P854) http://europepmc.org/abstract/MED/16467097

Allan R Li
(P1545) 4
(P248)
(P698) 16467097
(P813) Tuesday, December 26, 2017
(P854) http://europepmc.org/abstract/MED/16467097

Ennapadam S Venkatraman
(P1545) 6
(P248)
(P698) 16467097
(P813) Tuesday, December 26, 2017
(P854) http://europepmc.org/abstract/MED/16467097

Vincent A Miller
(P1545) 10
(P248)
(P698) 16467097
(P813) Tuesday, December 26, 2017
(P854) http://europepmc.org/abstract/MED/16467097

other details
description scientific article published in February 2006

External Links
(P356) 10.1158/1078-0432.CCR-05-1846
(P698) 16467097